Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Transgender Children, Puberty Blockers, and the Law: Solutions to the Problem of Dissenting Parents.

Coleman DL.

Am J Bioeth. 2019 Feb;19(2):82-84. doi: 10.1080/15265161.2018.1557297. No abstract available.

PMID:
31543023
2.

Developing Faculty in Emerging Areas of Interdisciplinary Research.

Coleman DL, Tannock LR, Pignone M, Amin AN, Finn PW.

Am J Med. 2018 Oct;131(10):1257-1262. doi: 10.1016/j.amjmed.2018.06.009. Epub 2018 Jul 5.

PMID:
29981720
3.

Integrating Social Determinants of Health Into Graduate Medical Education: A Call for Action.

Siegel J, Coleman DL, James T.

Acad Med. 2018 Feb;93(2):159-162. doi: 10.1097/ACM.0000000000002054.

PMID:
29140918
4.

Thrombotic Microangiopathy: A Multidisciplinary TeamĀ Approach.

Gordon CE, Chitalia VC, Sloan JM, Salant DJ, Coleman DL, Quillen K, Ravid K, Francis JM.

Am J Kidney Dis. 2017 Nov;70(5):715-721. doi: 10.1053/j.ajkd.2017.05.017. Epub 2017 Jul 15.

PMID:
28720207
5.

The Department of Medicine in 2030: A Look Ahead.

Coleman DL, Johnson DH.

Am J Med. 2016 Nov;129(11):1226-1233. doi: 10.1016/j.amjmed.2016.07.008. Epub 2016 Jul 30.

PMID:
27480389
6.

Strategies for Developing and Recognizing Faculty Working in Quality Improvement and Patient Safety.

Coleman DL, Wardrop RM 3rd, Levinson WS, Zeidel ML, Parsons PE.

Acad Med. 2017 Jan;92(1):52-57. doi: 10.1097/ACM.0000000000001230.

PMID:
27191838
7.
8.

The legal authority of mature minors to consent to general medical treatment.

Coleman DL, Rosoff PM.

Pediatrics. 2013 Apr;131(4):786-93. doi: 10.1542/peds.2012-2470. Epub 2013 Mar 25. Review.

PMID:
23530175
9.

Perspective: key indicators in academic medicine: a suggested framework for analysis.

Joiner KA, Coleman DL.

Acad Med. 2012 Feb;87(2):230-5. doi: 10.1097/ACM.0b013e31823faafb.

PMID:
22273616
10.

A historical perspective on leptin.

Coleman DL.

Nat Med. 2010 Oct;16(10):1097-9. doi: 10.1038/nm1010-1097. No abstract available.

PMID:
20930752
11.

WHERE AND HOW TO DRAW THE LINE BETWEEN REASONABLE CORPORAL PUNISHMENT AND ABUSE.

Coleman DL, Dodge KA, Campbell SK.

Law Contemp Probl. 2010 Spring;73(2):107-166. No abstract available.

12.

The problem of doping.

Coleman DL, Coleman JE Jr.

Duke Law J. 2008 Apr;57(6):1743-94. No abstract available.

PMID:
19108358
13.
14.

The legal ethics of pediatric research.

Coleman DL.

Duke Law J. 2007 Dec;57(3):517-624.

PMID:
18354870
15.

Attitudes of veterinary nurses to the assessment of pain and the use of pain scales.

Coleman DL, Slingsby LS.

Vet Rec. 2007 Apr 21;160(16):541-4.

PMID:
17449708
17.

Improving clinical productivity in the academic setting: a novel incentive plan based on utility theory.

Wilson MS, Joiner KA, Inzucchi SE, Mulligan GJ, Mechem MF, Gross CP, Coleman DL.

Acad Med. 2006 Apr;81(4):306-13.

PMID:
16565178
18.

Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.

Coleman DL, Kazdin AE, Miller LA, Morrow JS, Udelsman R.

Acad Med. 2006 Feb;81(2):154-60.

PMID:
16436576
19.

Measuring physicians' productivity in a Veterans' Affairs Medical Center.

Coleman DL, Moran E, Serfilippi D, Mulinski P, Rosenthal R, Gordon B, Mogielnicki RP.

Acad Med. 2003 Jul;78(7):682-9.

PMID:
12857686
20.

External review: both sides benefit.

Coleman DL.

Healthplan. 2000 Sep-Oct;41(5):26-30. No abstract available.

PMID:
11139998
21.

The scholarship of application.

Shapiro ED, Coleman DL.

Acad Med. 2000 Sep;75(9):895-8.

PMID:
10995610
22.

Building consumer trust. Across the country, health plans and policy makers are embracing external review programs.

Coleman DL.

Healthplan. 1999 Jul-Aug;40(4):50-5, 57. No abstract available.

PMID:
10557737
23.

Who's guarding medical privacy?

Coleman DL.

Bus Health. 1999 Mar;17(3):29-30, 32, 37-8. No abstract available.

PMID:
10387167
24.

Mental Health Parity: a year later, are we there?

Coleman DL.

Manag Care. 1999 Jan;8(1):17-8, 23. No abstract available.

PMID:
10346096
25.

A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase.

Coleman DL, Canak N, Place GD, Shih C, Bowsher RR.

Clin Cancer Res. 1998 Jan;4(1):157-63.

26.

Building an ethical framework.

Coleman DL.

Healthplan. 1998 Jan-Feb;39(1):36-41. No abstract available.

PMID:
10176896
27.

Glomerular epithelial cell products stimulate mesangial cell proliferation in culture.

Budde K, Neumayer HH, Salant DJ, Cybulsky AV, Coleman DL, Sterzel RB.

Kidney Int. 1997 Sep;52(3):733-41.

28.

Crushing your health plan's legal protection.

Coleman DL.

Bus Health. 1997 Aug;15(8):40-2, 44-6.

PMID:
10170211
29.

The law that shields HMOs from the risk doctors face.

Coleman DL.

Manag Care. 1997 May;6(5):25-6, 35-8, 41. No abstract available.

30.

Doctor, have you had your day out of court?

Coleman DL.

Manag Care. 1997 Apr;6(4):52-5. No abstract available.

31.

What's up on the Web.

Coleman DL.

Bus Health. 1997 Apr;15(4):51-3. No abstract available.

PMID:
10166792
32.

Will direct contractors be the cost and quality champs?

Coleman DL.

Bus Health. 1997 Mar;15(3):38-42. No abstract available.

PMID:
10165588
33.

Managing health benefits. The birth of the on-line age.

Coleman DL.

Bus Health. 1997 Jan;15(1):30-2, 37-8. No abstract available.

PMID:
10164137
34.

Four ways to avoid being deselected.

Coleman DL.

Manag Care. 1996 Nov;5(11):36-8. No abstract available.

35.

Tonsillar tissue penetration of dirithromycin after multiple doses.

Benson JM, Arnold J, Manning SC, Coleman DL, Sides GD, Conforti PM, Lemon E, Watkins VS.

J Clin Pharmacol. 1996 Sep;36(9):832-7.

PMID:
8889904
36.

'Any willing provider': a toothless tiger?

Coleman DL.

Manag Care. 1996 Apr;5(4):44-7. No abstract available.

PMID:
10157309
37.

Five ways physicians can catch an HMO's eye.

Coleman DL.

Manag Care. 1995 Dec;4(12):48-50. No abstract available.

PMID:
10153810
38.

According to whose standards of care?

Coleman DL.

Contemp Longterm Care. 1995 Apr;18(4):59. No abstract available.

PMID:
10143855
39.
40.
42.

PDGF-induced Egr-1 expression in rat mesangial cells is mediated through upstream serum response elements.

Rupprecht HD, Sukhatme VP, Lacy J, Sterzel RB, Coleman DL.

Am J Physiol. 1993 Sep;265(3 Pt 2):F351-60.

PMID:
8214093
43.

Lipopolysaccharide induces Egr-1 mRNA and protein in murine peritoneal macrophages.

Coleman DL, Bartiss AH, Sukhatme VP, Liu J, Rupprecht HD.

J Immunol. 1992 Nov 1;149(9):3045-51.

PMID:
1401930
44.

Effect of vasoactive agents on induction of Egr-1 in rat mesangial cells: correlation with mitogenicity.

Rupprecht HD, Dann P, Sukhatme VP, Sterzel RB, Coleman DL.

Am J Physiol. 1992 Oct;263(4 Pt 2):F623-36.

PMID:
1415734
46.

Mesangial cell-matrix interactions. Effects on mesangial cell growth and cytokine secretion.

Ruef C, Kashgarian M, Coleman DL.

Am J Pathol. 1992 Aug;141(2):429-39.

47.

Interleukin-6: an autocrine regulator of mesangial cell growth.

Coleman DL, Ruef C.

Kidney Int. 1992 Mar;41(3):604-6. Review. No abstract available.

48.

Patterns of failure of bulky-barrel carcinomas of the cervix.

Coleman DL, Gallup DG, Wolcott HD, Otken LB, Stock RJ.

Am J Obstet Gynecol. 1992 Mar;166(3):916-20.

PMID:
1550164
49.

Pharmacokinetics of cefaclor AF: effects of age, antacids and H2-receptor antagonists.

Satterwhite JH, Cerimele BJ, Coleman DL, Hatcher BL, Kisicki J, DeSante KA.

Postgrad Med J. 1992;68 Suppl 3:S3-9.

PMID:
1287615
50.

Transfection of adherent murine peritoneal macrophages with a reporter gene using DEAE-dextran.

Rupprecht AP, Coleman DL.

J Immunol Methods. 1991 Nov 22;144(2):157-63.

PMID:
1960412

Supplemental Content

Loading ...
Support Center